Sign Out
Use in pregnancy: Calcitriol given orally has been reported to be teratogenic in rabbits when given in doses 4 and 15 times the dose recommended for human use. All 15 fetuses in 3 L at these doses showed external and skeletal abnormalities however, none of the other 23 letters (156 fetuses) showed significant abnormalities compared with controls.
Teratology studies in rats showed no evidence of teratogenic potential.
Safety and efficacy in pregnant women have not been established.
Calomin Inj should be used during pregnancy only if the potential benefit justifies potential risk to the fetus.
Use in lactation: It is not known whether Calomin Inj is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reaction in nursing infants from calcitriol, a decision should be made whether to discontinue nursing or to discontinue Calomin Inj, taking into account the importance of the drug to the mother.
